4 October 2024 in PLOS ONE
RNRayssa Maite Farias Nazario
Rayssa Maite Farias Nazario
VCVictoria dos Santos Chemelo
Victoria dos Santos Chemelo
+7
This study aimed to investigate the impact of minocycline on the alveolar bone in experimental periodontitis in rats. Thirty Wistar rats were randomly assigned to three groups: control without periodontitis; experimental periodontitis induced by ligature; experimental periodontitis + intraperitoneal administration minocycline for seven days. Ligatures remained in place in both periodontitis groups for 14 days. At the end of the experiment, the animals were euthanized and one hemimandible underwent micro-computed tomography (micro-CT) analysis to assess vertical bone loss and alveolar bone quality. Histopathological analysis was performed on the other hemimandible. Statistical analysis was performed using ANOVA with Tukey’s post-test (p<0.05). The results showed a significant reduction in vertical bone loss in the animals treated with minocycline compared with untreated animals. Minocycline also preserved the alveolar bone thickness, number, spacing, and bone volume to tissue volume ratio. Histopathological analysis indicated that minocycline reduced bone resorption, decreased inflammatory response, and maintained the bone collagen fibers. This study demonstrated the effectiveness of minocycline in reducing vertical bone loss and preserved bone quality in rats with experimental periodontitis. The results of this study indicate that minocycline has the potential to serve as an additional treatment option for periodontitis. However, further research is warranted to assess the efficacy and safety of minocycline use in patients with periodontitis.
5 November 2024 in Heliyon
MFMaria Karolina Martins Ferreira
Maria Karolina Martins Ferreira
+6
This study aimed to evaluate the effects of excessive and episodic consumption of ethanol (EtOH, a high-intensity drinking manner) on induced apical periodontitis in rats. Thirty-two animals were divided into the following four groups: control, EtOH, apical periodontitis, and EtOH + apical periodontitis. Ethanol exposure (3 g/kg 20 % w/v EtOH) was performed by orogastric gavage for 3 consecutive days, followed by 4 days of withdrawal for 4 weeks. Lesions were induced by exposing the dental pulp of the lower first molar and by the absence of any treatment/curative for 28 days. Finally, the animals were euthanized, and mandibles were collected. The mandible was divided medially, with one hemimandible being used for micro-computed tomography analysis of the volume of the periapical lesion and bone quality parameters, such as bone volume and trabecular bone assessments; the other hemimandible was used for histological analysis, with a descriptive histopathological analysis of the tissue and the pattern of bone loss presented, as well as an assessment of the collagen content present. The data were subjected to statistical analysis (one-way analysis of variance with Tukey's post-hoc test). Our results showed that the EtOH + apical periodontitis group had a larger volume of periapical lesions than animals that were not exposed to ethanol. Additionally, bone quality parameters showed a reduction in bone volume and thickening of the trabeculae, associated with increased tissue destruction and reduced collagen content in the remnant region of the alveolar bone. These results suggest that exposure to EtOH in a pattern of excessive alcohol consumption is an aggravating factor in apical periodontitis and, consequently, in its progression, the quality and quantity of the alveolar bone remaining in the region of the periapical lesion are the modulating aspects.
22 August 2025 in Naunyn-Schmiedeberg's Archives of Pharmacology
WMWallacy Watson Pereira Melo
Wallacy Watson Pereira Melo
VSVinicius Ruan Neves dos Santos
Vinicius Ruan Neves dos Santos
CPCristian dos Santos Pereira
Cristian dos Santos Pereira
PMPaulo Fernando Santos Mendes
Paulo Fernando Santos Mendes
+5
21 November 2025 in International Endodontic Journal
Aim: This study aimed to investigate the effects of copaiba oil–resin on induced apical periodontitis in rats. Methodology: A total of 24 male Wistar rats were divided equally into three groups (eight animals each): control (C), apical periodontitis (AP) and apical periodontitis with copaiba administration (AP + COP). The AP was induced by exposing the pulp chambers of the mandibular first molars to the oral environment. The openings were maintained for 28 days to allow lesion development. The AP + COP group received systemic administration of 200 mg/kg of copaiba oil–resin via intragastric gavage during the final 7 days of the AP induction period. The rats were then euthanised, and their hemimandibles were subjected to histopathological analysis to assess tissue preservation, histochemical staining with picrosirius red to evaluate collagen content, and microcomputed tomography to assess lesion volume and bone quality parameters. Statistical analyses were performed using a one‐way ANOVA, followed by Tukey's post hoc test for parametric data and the Kruskal–Wallis test for nonparametric data. The results are expressed as mean and standard error of the mean for parametric tests, and median and interquartile deviation for the nonparametric test. Results: The findings showed that copaiba oil–resin reduced lesion volume compared to the untreated group ( p = 0.0261), as well as reducing the space between the bone trabeculae found in the AP group ( p = 0.0063). Additionally, copaiba oil–resin preserved the collagen fibres, which were more degraded in the untreated group ( p = 0.0009). Histopathological analysis showed that copaiba oil–resin reduced tissue damage, preserving a significant area of alveolar bone surrounding the lesion. Conclusions: These results indicate that copaiba oil resin has a promising adjunct therapeutic potential to reduce the bone loss caused by apical periodontitis and contribute to the maintenance of quality in the remaining bone.
24 July 2026 in Journal of Oral Rehabilitation
ASAna Paula de Andrade Silva
Ana Paula de Andrade Silva
ZSZuleni Alexandre da Silva
Zuleni Alexandre da Silva
+2
Background: Burning Mouth Syndrome (BMS) is a type of chronic orofacial pain characterised by a burning sensation inside the mouth without an apparent cause. Capsaicin has been used to manage the symptoms of this syndrome, but there is still no consensus on its effectiveness. Objective: To assess whether capsaicin, when used topically or systemically, is able to alleviate the symptoms of BMS. Methods: An extensive search was carried out in seven databases and grey literature up to November 2025. There were no restrictions regarding the date or language of publication. Results: The search resulted in 782 articles, of which 4 were included. The methodological quality of the studies was assessed using the Risk of Bias in Systematic Reviews (ROBIS) tool and the certainty of evidence was performed according to Grading of Recommendations, Assessment, Development and Evaluation (GRADE). Regarding capsaicin administration, 3 studies used topical application and 1 used systemic application. Concentrations ranged from 0.000354% to 0.25%, three times a day, for 1–8 weeks. Regardless of the administration method, a reduction in patient‐reported pain scores was observed. Risk of bias assessment showed that three randomised studies presented a moderate risk, while the only non‐randomised clinical trial presented a critical risk. The overall certainty of the evidence was low or very low for the outcomes assessed. Conclusion: Evidence suggests that capsaicin is effective in relieving BMS symptoms. However, this result should be interpreted with caution due to the low quality of the evidence obtained to support its use.